INS and fatty liver disease: IR is a pathological condition in which insulin-mediated glucose uptake is impaired in insulin-sensitive tissue and plays a pivotal role in the pathogenesis of obesity-related metabolic diseases, such as type 2 diabetes mellitus, fatty liver disease, and cardiovascular disease [7,8].